215 related articles for article (PubMed ID: 30946512)
21. MLH1 intronic variants mapping to + 5 position of splice donor sites lead to deleterious effects on RNA splicing.
Piñero TA; Soukarieh O; Rolain M; Alvarez K; López-Köstner F; Torrezan GT; Carraro DM; De Oliveira Nascimento IL; Bomfim TF; Machado-Lopes TMB; Freitas JC; Toralles MB; Sandes KA; Rossi BM; Junior SA; Meira J; Dominguez-Valentin M; Møller P; Vaccaro CA; Martins A; Pavicic WH
Fam Cancer; 2020 Oct; 19(4):323-336. PubMed ID: 32363481
[TBL] [Abstract][Full Text] [Related]
22. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
23. Association of a novel frameshift variant and a known deleterious variant in MMR genes with Lynch syndrome in Chinese families.
Li J; Ni H; Wang X; Cheng W; Li L; Cheng Y; Liu C; Li Y; Deng A
World J Surg Oncol; 2024 Jan; 22(1):36. PubMed ID: 38280988
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers.
Goverde A; Spaander MCW; Nieboer D; van den Ouweland AMW; Dinjens WNM; Dubbink HJ; Tops CJ; Ten Broeke SW; Bruno MJ; Hofstra RMW; Steyerberg EW; Wagner A
Fam Cancer; 2018 Jul; 17(3):361-370. PubMed ID: 28933000
[TBL] [Abstract][Full Text] [Related]
25. Update on Lynch syndrome genomics.
Peltomäki P
Fam Cancer; 2016 Jul; 15(3):385-93. PubMed ID: 26873718
[TBL] [Abstract][Full Text] [Related]
26. Detection of
Okkels H; Lagerstedt-Robinsson K; Wikman FP; Hansen TVO; Lolas I; Lindberg LJ; Krarup HB
Genet Test Mol Biomarkers; 2019 Sep; 23(9):688-695. PubMed ID: 31433215
[No Abstract] [Full Text] [Related]
27. Mismatch repair deficiency in Lynch syndrome-associated colorectal adenomas is more prevalent in older patients.
Tanaka M; Nakajima T; Sugano K; Yoshida T; Taniguchi H; Kanemitsu Y; Nagino M; Sekine S
Histopathology; 2016 Aug; 69(2):322-8. PubMed ID: 26826556
[TBL] [Abstract][Full Text] [Related]
28. Pilot study of gene mutations associated with Lynch syndrome in Slovak patients with breast cancer.
Krasničanová L; Saade R; Priščáková P; Gbelcová H; Kaľavská K; Karaba M; Benca J; Mego M; Repiská V
Klin Onkol; 2023; 36(2):130-134. PubMed ID: 37072247
[TBL] [Abstract][Full Text] [Related]
29. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity.
Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z
Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
[TBL] [Abstract][Full Text] [Related]
31. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
32. An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome.
Suerink M; Rodríguez-Girondo M; van der Klift HM; Colas C; Brugieres L; Lavoine N; Jongmans M; Munar GC; Evans DG; Farrell MP; Genuardi M; Goldberg Y; Gomez-Garcia E; Heinimann K; Hoell JI; Aretz S; Jasperson KW; Kedar I; Modi MB; Nikolaev S; van Os TAM; Ripperger T; Rueda D; Senter L; Sjursen W; Sunde L; Therkildsen C; Tibiletti MG; Trainer AH; Vos YJ; Wagner A; Winship I; Wimmer K; Zimmermann SY; Vasen HF; van Asperen CJ; Houwing-Duistermaat JJ; Ten Broeke SW; Nielsen M
Genet Med; 2019 Dec; 21(12):2706-2712. PubMed ID: 31204389
[TBL] [Abstract][Full Text] [Related]
33. Screening for germline mutations in mismatch repair genes in patients with Lynch syndrome by next generation sequencing.
Soares BL; Brant AC; Gomes R; Pastor T; Schneider NB; Ribeiro-Dos-Santos Â; de Assumpção PP; Achatz MIW; Ashton-Prolla P; Moreira MAM
Fam Cancer; 2018 Jul; 17(3):387-394. PubMed ID: 28932927
[TBL] [Abstract][Full Text] [Related]
34. Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency.
Clay MR; Allison KH; Folkins AK; Longacre TA
Am J Surg Pathol; 2014 Nov; 38(11):1494-500. PubMed ID: 24921635
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of heterozygous
Wang Q; Leclerc J; Bougeard G; Olschwang S; Vasseur S; Cassinari K; Boidin D; Lefol C; Naïbo P; Frébourg T; Buisine MP; Baert-Desurmont S;
J Med Genet; 2020 Jul; 57(7):487-499. PubMed ID: 31992580
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of CNV-neutral structural genomic rearrangements in MLH1, MSH2, and PMS2 not detectable in routine NGS diagnostics.
Morak M; Steinke-Lange V; Massdorf T; Benet-Pages A; Locher M; Laner A; Kayser K; Aretz S; Holinski-Feder E
Fam Cancer; 2020 Apr; 19(2):161-167. PubMed ID: 32002723
[TBL] [Abstract][Full Text] [Related]
37. Induction of mismatch repair deficiency, compromised DNA damage signaling and compound hypermutagenesis by a dietary mutagen in a cell-based model for Lynch syndrome.
Ijsselsteijn R; van Hees S; Drost M; Jansen JG; de Wind N
Carcinogenesis; 2022 Mar; 43(2):160-169. PubMed ID: 34919656
[TBL] [Abstract][Full Text] [Related]
38. Cancer Risks for PMS2-Associated Lynch Syndrome.
Ten Broeke SW; van der Klift HM; Tops CMJ; Aretz S; Bernstein I; Buchanan DD; de la Chapelle A; Capella G; Clendenning M; Engel C; Gallinger S; Gomez Garcia E; Figueiredo JC; Haile R; Hampel HL; Hopper JL; Hoogerbrugge N; von Knebel Doeberitz M; Le Marchand L; Letteboer TGW; Jenkins MA; Lindblom A; Lindor NM; Mensenkamp AR; Møller P; Newcomb PA; van Os TAM; Pearlman R; Pineda M; Rahner N; Redeker EJW; Olderode-Berends MJW; Rosty C; Schackert HK; Scott R; Senter L; Spruijt L; Steinke-Lange V; Suerink M; Thibodeau S; Vos YJ; Wagner A; Winship I; Hes FJ; Vasen HFA; Wijnen JT; Nielsen M; Win AK
J Clin Oncol; 2018 Oct; 36(29):2961-2968. PubMed ID: 30161022
[TBL] [Abstract][Full Text] [Related]
39. Mismatch Repair Protein Expression in Endometrioid Intraepithelial Neoplasia/Atypical Hyperplasia: Should We Screen for Lynch Syndrome in Precancerous Lesions?
Lucas E; Chen H; Molberg K; Castrillon DH; Rivera Colon G; Li L; Hinson S; Thibodeaux J; Lea J; Miller DS; Zheng W
Int J Gynecol Pathol; 2019 Nov; 38(6):533-542. PubMed ID: 30383610
[TBL] [Abstract][Full Text] [Related]
40. Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous Prostate Cancer with Intact MMR: Diagnosis and Analysis of the Family Pedigree.
Liu W; Zhang D; Tan SA; Liu X; Lai J
Anticancer Res; 2018 Aug; 38(8):4847-4852. PubMed ID: 30061258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
